Supernus Pharmaceuticals to Participate in June Investor Conferences

On May 27, 2026 Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, reported that management will participate in the following June investor conferences:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2026 Jefferies Global Healthcare Conference
Date:
Fireside chat:
Place:
Webcast Link:
Wednesday, June 3, 2026
10:30 a.m. ET
Marriott Marquis, New York, NY
Here

Goldman Sachs 47th Annual Global Healthcare Conference
Date:
Place:
Monday, June 8, 2026
Loews Miami Beach, Miami Beach, Fla.

Investors interested in arranging a meeting with the Company’s management during these conferences should contact the respective conference coordinators.

A live audio webcast of the Jefferies Global Healthcare Conference can also be accessed on the Events & Presentations section of the Supernus Pharmaceuticals website at www.supernus.com. Archived replays of the webcast will be available for 60 days on the Company’s website following the conference.

(Press release, Supernus, MAY 27, 2026, View Source [SID1234666103])